Sintx Technologies, Inc. (0A8S.L)

0.0353 -0.0029 (-7.66%) At close: 03:43PM BST

Sintx Technologies, Inc.

1885 West 2100 South
Salt Lake City, UT 84119
United States
801 839 3500
https://www.sintx.com

Sector(s): 
Industry: 
Full-time employees: 43

Key executives

Name	Title	Pay	Exercised	Year born
Dr. B. Sonny Bal J.D., M.B.A., M.D., Ph.D.	CEO, President, Principal Financial Officer & Chairman	460.81k	N/A	1962
Mr. David Francis O'Brien	Executive VP & COO	432.46k	N/A	1965
Mr. Michael Marcroft	Vice President of Sales & Marketing	N/A	N/A	N/A
Ms. Gina Moss	Director of Operations	N/A	N/A	N/A

Amounts are as of 31 December 2023, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Sintx Technologies, Inc., an advanced materials company, engages in the research, development, and commercialization of medical devices manufactured with silicon nitride for biomedical, industrial, and antipathogenic applications in the United States. It provides solid and porous silicon nitride; silicon nitrite powder; and silicon nitride coating products, as well as silicon nitride composite materials and polyetherketoneketone. The company was formerly known as Amedica Corporation. Sintx Technologies, Inc. was incorporated in 1996 and is headquartered in Salt Lake City, Utah.

Corporate governance

Sintx Technologies, Inc.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.